MITCHELL HALPER: Open Payments
NPI 1205039658 · ST CHARLES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 21 payments from 8 companies in 2025. Trend: 2023 $4,744 · 2024 $2,185 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $118 |
| ABBVIE INC. | 6 | $111 |
| Corium, LLC | 5 | $81 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $36 |
| Collegium Pharmaceutical, Inc. | 1 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, Azstarys, AUSTEDO XR, UZEDY, Auvelity, INGREZZA, Jornay PM, COBENFY.
Industry payments across IL — which companies pay providers there.
